Stockreport

Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting

Homology Medicines, Inc.  (FIXX) 
Last homology medicines, inc. earnings: 3/12 04:10 pm Check Earnings Report
PDF - Additional Presentation Focused on Use of Single-Molecule, Modified Base Sequencing to Support Vector Design - BEDFORD, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Hom [Read more]